Half Beta-Prograne (Propranolol Hydrochloride)

Half Beta‑Prograne is prescribed for several cardiovascular and neurological indications where beta‑adrenergic blockade is beneficial.

• Hypertension (high blood pressure)
• Angina pectoris (chest pain due to coronary artery disease)
• Cardiac arrhythmias (including supraventricular and ventricular types)
• Migraine prophylaxis (prevention of migraine attacks)
• Essential tremor (tremor control)
• Adjunct therapy for hyperthyroidism symptoms

Side effects of propranolol may vary in frequency and severity; patients should be aware of both common and serious reactions.

Common

• Fatigue or tiredness
• Dizziness or light‑headedness
• Cold hands and feet
• Nausea, abdominal discomfort or diarrhea
• Sleep disturbances or vivid dreams
• Mild depressive mood

Serious

• Marked bradycardia (slow heart rate)
• Significant hypotension (low blood pressure)
• Heart block or worsening arrhythmias
• Bronchospasm or severe asthma exacerbation
• Severe depression, suicidal thoughts, or psychosis
• Hypoglycemia, especially in patients with diabetes

Before starting Half Beta‑Prograne, clinicians should evaluate several precautionary factors to ensure safe use.

• Assess baseline cardiac function, heart rate, and blood pressure
• Avoid use in patients with severe asthma, chronic obstructive pulmonary disease, or active bronchospasm
• Monitor blood glucose closely in diabetic patients, as propranolol may mask hypoglycemia symptoms
• Use caution in individuals with peripheral vascular disease or Raynaud’s phenomenon
• Adjust dose in patients with hepatic or renal impairment
• Review all concomitant medications that affect heart rate or blood pressure
• Prescribe only when the potential benefit outweighs risk in pregnant or breastfeeding women

Propranolol can interact with a range of medicines; some combinations should be avoided while others require careful monitoring.

Avoid

• Other non‑selective beta blockers
• Calcium‑channel blockers such as verapamil or diltiazem that may cause excessive bradycardia
• Abrupt discontinuation of clonidine
• Monoamine oxidase inhibitors (MAOIs)
• Certain anti‑arrhythmic agents (e.g., amiodarone)

Use with caution

• Other antihypertensives (ACE inhibitors, diuretics, other beta blockers)
• Antidiabetic agents (insulin, sulfonylureas) due to hypoglycemia risk
• Antidepressants (SSRIs, tricyclics) that may affect cardiac conduction
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) which can blunt antihypertensive effect
• Thyroid hormone replacement therapy